Advances In Cancer Research

Superior Essays
Typically, when people hear the phrase “cancer treatment”, they think of chemotherapy, tumor removal surgery, or radiology. Many people don’t realize what other options are now available or being researched and studied. Treatment of this disease is rapidly growing and changing due to the development of new scientific technology. Advances in cancer research have led to the development of new types of therapies used to treat cancer. One of these treatment methods is called immunotherapy, which utilizes the body’s own immune system to attack the cancerous cells. There are many different types of immunotherapy, some of which include cancer vaccines, oncolytic virus therapy, and non-specific monoclonal antibodies (cancer.net).
Cancer cells affect
…show more content…
It is a therapeutic vaccine that is used to treat certain advanced prostate cancers (fda). According to Gaines, the way it works is by causing the patient’s own immune system to attack an antigen called prostatic acid phosphates, present in the majority of prostate cancers. Before a dose is administered, a procedure called a leukapheresis must be carried out. During this process, blood from the patient is filtered and platelets and monocytes are removed and of the results is antigen producing cells, or APCs. The APCs are incubated with a protein that bind to them and are broken into smaller units that can cause the immune system to attack the prostatic acid phosphates. The cells that resulted from the leukapheresis are necessary for the success and composition of the vaccine (2012). During clinical trials, this drug increased survival over the next three years by 31.7%, displaying an increase in median survival of over four months (Gaines, 2012). Sipuleucel-T is hopefully just the first of numerous more cancer vaccines that will be approved in the future. Advances in immunology has shown great success in the treatment of advanced prostate …show more content…
During this type of therapy, viruses that have been altered genetically are injected into a patient’s tumor which spark a serious of steps. First, after entering the tumor, the virus infiltrates the malicious cells, causing them to rupture and die. When the cells are rupturing they give off antigens, or toxins, that prompt the immune system to attack all of the cancerous cells in the body (Cancer.net, 2016). A practical example of this treatment method, is used to treat melanoma on skin and lymph nodes. It it called talimogene laherparepvec (T-VEC) and it was approved in October 2015 (fda.org, 2015). T-VEC uses a modified herpes simplex virus that not only attacks the cancer cells but enhances the body’s defenses against possible reoccurring melanoma (Dolgin, 2015). This treatment is administered as a set of several injections directly into the melanomas at very specific, designed points in time for six months or until they can be injected into. This immunologic approach for skin cancer is revolutionary, as it is a very serious disease that can make its way throughout the body, causing it to become more dangerous and much harder to treat

Related Documents

  • Improved Essays

    Ccr5 Unit 1 Term Paper

    • 437 Words
    • 2 Pages

    The new treatment being studied involves removing white blood cells from the blood that contains CD4+ T-Cells. The CD4+ T-Cells that are extracted are then genetically modified by the ZFNs to be resistant to infection by HIV by removing the CCR5 gene from the surface of the CD4+ T Cell where the HIV enters the cell. Researchers anticipate that the modified cells will be resistant to infection by HIV and will be able to reproduce more resistant CD4+ T-Cells in your body.…

    • 437 Words
    • 2 Pages
    Improved Essays
  • Improved Essays

    Nivolumab Case Studies

    • 949 Words
    • 4 Pages

    The antitumor effect of nivolumab in the melanoma regiment was followed by another trial with 107 patients, where 31% of the patients had an impartial response, with a median duration for 2 years. Of these responders, 15 responded to the therapy by 8 weeks during the first assessment, 12 had continued responses for minimum of 4 months after ending the therapy, while 17 had responses but left the program unexpectedly. Now, nivolumab use has achieved an improved outcome in patients with melanoma and NSCLC (Mahoney et al. 764-782). Moreover, a Phase III trial was conducted in melanoma, where nivolumab was compared to dacarbazine.…

    • 949 Words
    • 4 Pages
    Improved Essays
  • Improved Essays

    RT AND TLR AGONISTS TLR agonists can be used in combination with RT to enhance the antitumor immune response. This combination therapy was more efficient than either treatment alone and provided protection against subsequent tumor rechallenges. Brody et al treated 15 patients with metastatic low-grade B cell lymphomas with low doses of radiation (2 x 2 Gy in 2 consecutive days). They combined the RT with intratumoral injections of CpG, into the same irradiated site, before the first dose of radiation, after the second dose and then weekly for 8 weeks . This in situ vaccination maneuver was well tolerated with only grades 1 to 2 local or systemic reactions and no treatment-limiting adverse events were observed.…

    • 360 Words
    • 2 Pages
    Improved Essays
  • Improved Essays

    One of the most common known Sexual Transmitted Diseases (STD’s) that has become a global health issue is the Human Immunodeficiency Virus better known as HIV. HIV targets the immune system and weakens people’s surveillance and defense systems against infections and some types of cancer (WHO, 2014). HIV targets specific cells in the immune system they are the CD4 cells or preferably known as T cells (CDC, 2015). HIV has different symptoms depending on the stage the virus is in. The reason so many people have HIV is because in the beginning the contaminated person does not know they have the virus thus, leading to the spread of the virus.…

    • 902 Words
    • 4 Pages
    Improved Essays
  • Decent Essays

    PRL-3 Case Study

    • 46 Words
    • 1 Pages

    In addition, the induction of anti–PRL-3 antibody in the host immune system upon vaccination could specifically inhibit the formation of PRL-3-expressing tumors (212-216). For instance, targeting PRL-3 using PRL-3-targeted DNA vaccine can suppress breast cancer tumor growth through the induction of cellular immune responses to…

    • 46 Words
    • 1 Pages
    Decent Essays
  • Improved Essays

    The Benefits Of Melanoma

    • 818 Words
    • 4 Pages

    This adventure also lead to the creation of melanoma vaccines. Even though the T-cell have low cupidity, advancement in technology had enabled researches to calculate “antigen T-cells reproducibly.” Overcoming the fact that immune system has evolved to avoid reacting against self-antigens, it remains as a major challenge in the development of cancer vaccines. There are different kinds of cancer vaccines. One of them is Allogeneic Vaccines.…

    • 818 Words
    • 4 Pages
    Improved Essays
  • Decent Essays

    Panitumumab (Vectibix ®) is a targeted therapy drug that is mainly used to treat advanced bowel cancer. Panitumumab belongs to a group of cancer drugs known as monoclonal antibodies. These drugs are sometimes called targeted therapies. They work by ‘targeting’ specific proteins (receptors) on the surface of cells.…

    • 106 Words
    • 1 Pages
    Decent Essays
  • Improved Essays

    A Modest Proposal

    • 1341 Words
    • 6 Pages

    State of the Problem In its variety of forms, cancer is estimated to affect more than 14 million people per year, and is the cause the death of more than 8 million (National Cancer Institute). Despite millions of dollars of research in the field, and a concentrated effort by researchers around the globe, a panacea for cancer doesn’t exist, although much headway has been made in earlier detection and better treatment methods. Much of the difficulty in treating the disease lies in its diversity; cancer is as varied as it is deadly.…

    • 1341 Words
    • 6 Pages
    Improved Essays
  • Improved Essays

    The primary inflammatory cytokines: Tumor necrosis factor (TNF) is a proinflammatory cytokine which is produced by macrophages, T cells, B cells, natural killer cells, fibroblasts, neutrophils, keratinocytes and tumor cells [13]. It is produced during early inflammatory response. It mediates the production of other cytokines, chemokines and adhesion molecules [14]. It also increases vascular permeability, which leads to migration of activated immune cells to the site of infection [15,16]. TNF is a promoter of inflammation, angiogenesis and tumor dissemination and therefore a tumor-promoting factor [17,18].…

    • 1339 Words
    • 6 Pages
    Improved Essays
  • Improved Essays

    Treating Myeloma Analysis

    • 276 Words
    • 2 Pages

    Overall, this video explains the positive outcomes of using viruses, that once were considered deadly, to treat cancer. The documentary shows how ongoing research and trials of this kind of treatment is happening simultaneously in different places, and using different viruses. The first case mentions the study developed by Dr. Bell, who concluded that smallpox viruses can attack, and kill cancer cells without harming surrounding cells. Therefore, he and his team are working in treatment trials using vaccines containing genetically engineered smallpox viruses. On the other hand, Dr. Rusell came to a similar conclusion by treating myeloma, an extremely aggressive cancer, with a modified measles virus.…

    • 276 Words
    • 2 Pages
    Improved Essays
  • Improved Essays

    Passive Targeting

    • 364 Words
    • 2 Pages

    The major problem associated with chemotherapeutic agents is their lack of specificity and selectivity. This is mainly due to the presence of very subtle metabolic differences between the tumor cells and the normal cells[51]. Hence, very large doses of chemotherapeutic drugs are required for successful chemotherapy. Furthermore, cancer chemotherapy leads to severe adverse effects, such as hair loss, damages to the liver, kidney, and bone marrow, as the normal cells are also exposed to these cytotoxic agents[52]. A lot of research efforts have therefore been directed to improve the specificity of anticancer agents[53, 54].…

    • 364 Words
    • 2 Pages
    Improved Essays
  • Decent Essays

    Every individual is under constant attack from an enormous range of potentially harmful invaders. These threats include such diverse pathogens such as bacteria, viruses, cancer cells and parasite cells. The body has two methods of immunity that defend the body against these pathogens; this includes the innate and adaptive immunity. The challenge of comparing and contrasting the biological processes underlying innate and the adaptive immunity will be no easy task never the less.…

    • 92 Words
    • 1 Pages
    Decent Essays
  • Superior Essays

    Innovative technology and cancer research surround today’s world; experts are learning new things daily. At first glance, chemotherapy or radiation therapy seem to be the only options of treatment; however, this…

    • 1504 Words
    • 7 Pages
    Superior Essays
  • Improved Essays

    1.10 Prognosis Main goal of treatment is to improve life expectancy, durable haematological response to reduce risk of relapse or clonal evolution (165). Haemopoietic response of the patients taking IST is up to 74% with long term survival rate of about 90% while 20-40% responders show a relapse (166).…

    • 1070 Words
    • 5 Pages
    Improved Essays
  • Improved Essays

    Malignant tumors rapidly spread throughout the body, attacking tissues and the surrounding regions. The only cure for this tumor…

    • 815 Words
    • 4 Pages
    Improved Essays